Literature DB >> 1892065

Coronary thrombosis: pathogenesis and clinical manifestations.

E Falk1.   

Abstract

The majority (greater than 75%) of major coronary thrombi are precipitated by a sudden rupture of the surface of an atherosclerotic plaque (plaque fissuring) causing platelet aggregation where thrombogenic subendothelial tissue has been exposed. Whether the thrombus remains mural and limited, just sealing the rupture, or evolves into an occlusive thrombus seems to depend on: (1) the amount and character of exposed thrombogenic material; (2) the actual thrombotic-thrombolytic equilibrium; and (3) local flow disturbances due to preexisting atherosclerotic stenosis. Thrombus formation may take place within the stenosis, where blood velocity and shear forces are highest, or it may take place or extend poststenotically, where flow separation, recirculation, and turbulence prevail. Platelet aggregation within the stenosis is responsible for the primary flow obstruction, but fibrin subsequently enmeshes the platelets and thus stabilizes the thrombus. Most thrombi have a layered structure, indicating an episodic growth that may alternate with thrombus fragmentation and peripheral embolization: thrombosis and thrombolysis are dynamic processes occurring simultaneously. If the platelet-rich thrombus at the rupture site evolves into an occlusive thrombus, the blood proximal and distal to the occlusion may stagnate and coagulate, giving rise to a secondarily formed red stagnation thrombosis consisting predominantly of erythrocytes held together by fibrin membranes. A ruptured plaque with a dynamic thrombosis superimposed (with or without spasm) seems to underlie the great majority of acute ischemic syndromes: unstable angina, acute infarction, and sudden death. The clinical presentation and the outcome depend on the severity and duration of ischemia: whether the obstruction is occlusive or nonocclusive, transient or persistent--modified by the magnitude of collateral flow.

Entities:  

Mesh:

Year:  1991        PMID: 1892065     DOI: 10.1016/0002-9149(91)90382-u

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  31 in total

1.  Holmium Laser-Induced Coronary Thrombolysis.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  The emerging role of thrombus aspiration in contemporary percutaneous coronary intervention practice.

Authors:  W G Wieringa; F Zijlstra
Journal:  Neth Heart J       Date:  2010-09       Impact factor: 2.380

Review 3.  Recognition and treatment of unstable angina.

Authors:  C Brunelli; P Spallarossa; P Rossettin; S Caponnetto
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

Review 4.  Sonothrombolysis.

Authors:  Kenneth B Bader; Guillaume Bouchoux; Christy K Holland
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 5.  Statin treatment and progression of atherosclerotic plaque burden.

Authors:  Diederick E Grobbee; Michiel L Bots
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 6.  The role of noninvasive imaging in promoting cardiovascular health.

Authors:  Valentin Fuster; Torsten P Vahl
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

Review 7.  Mechanisms of restenosis.

Authors:  W Casscells; D Engler; J T Willerson
Journal:  Tex Heart Inst J       Date:  1994

Review 8.  The fat-fed apolipoprotein E knockout mouse brachiocephalic artery in the study of atherosclerotic plaque rupture.

Authors:  Andrew R Bond; Christopher L Jackson
Journal:  J Biomed Biotechnol       Date:  2010-11-07

9.  Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques.

Authors:  Fabio R Tavora; Mary Ripple; Ling Li; Allen P Burke
Journal:  BMC Cardiovasc Disord       Date:  2009-06-23       Impact factor: 2.298

10.  Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration.

Authors:  Youlan L Gu; Marieke L Fokkema; Marthe A Kampinga; Bart J G L de Smet; Eng S Tan; Ad F M van den Heuvel; Felix Zijlstra
Journal:  Trials       Date:  2009-09-28       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.